Showing results (1891-1900 of 1,996) with videos related to
Sort By:
Pageof 200
The Lancet. Neurology|June 24, 2019
Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional studyHeather Wilson, George Dervenoulas, Gennaro Pagano, et al.The Lancet. Neurology|June 28, 2017
Gadolinium deposition in the brain: summary of evidence and recommendationsVikas Gulani, Fernando Calamante, Frank G Shellock, et al.The Lancet. Neurology|March 2, 2010
New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS)Leo H Bonati, Lisa M Jongen, Sven Haller, et al.The Lancet. Neurology|August 21, 2016
Safety and efficacy of amiselimod in relapsing multiple sclerosis (MOMENTUM): a randomised, double-blind, placebo-controlled phase 2 trialLudwig Kappos, Douglas L Arnold, Amit Bar-Or, et al.The Lancet. Neurology|April 14, 2023
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 studyVera Bril, Artur Drużdż, Julian Grosskreutz, et al.The Lancet. Neurology|April 24, 2021
Associations between lifestyle and amyotrophic lateral sclerosis stratified by C9orf72 genotype: a longitudinal, population-based, case-control studyHenk-Jan Westeneng, Kevin van Veenhuijzen, Rick A van der Spek, et al.The Lancet. Neurology|March 15, 2015
Axon guidance proteins in neurological disordersEljo Y Van Battum, Sara Brignani, R Jeroen PasterkampThe Lancet. Neurology|August 4, 2012
Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trialBrajesh K Lal, Kirk W Beach, Gary S Roubin, et al.The Lancet. Neurology|September 11, 2012
Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trialBruno Vellas, Nicola Coley, Pierre-Jean Ousset, et al.The Lancet. Neurology|September 7, 2012
Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control studyJennifer L Whitwell, Dennis W Dickson, Melissa E Murray, et al.Pageof 200